StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$11.74−1.01 (-7.92%)

Close on Nov 17, 2026Market cap $79.70MP/E –Yield –

Eloxx Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eloxx Pharmaceuticals's price to book ratio was 1.1× on Nov 11, 2026, against 24.5× a year earlier. Over the last 5 years it ranged from 1.1× to 382.7×, with a median of 57.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−8.0
2023Jul 31, 20239.1×−66.7
2022Oct 31, 202275.9×+55.4
2021Dec 31, 202120.4×−96.2
2020Dec 31, 2020116.6×+45.0
2019Dec 31, 201971.6×−18.6
2018Dec 31, 201890.2×−305.3
2017Dec 29, 2017395.5×–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?